| Mepha Pharma AG - Zolmitriptan-Mepha oro, Schmelztabletten | | 61067 | | 01 | | Zolmitriptan-Mepha oro | | Schmelztabletten | | N02CC03 | | Zolmitriptan | | 27.05.2011 | | |
| | Composition | | zolmitriptanum 2.5 mg, silica colloidalis anhydrica, lactosum monohydricum 17 mg, maydis amylum, mannitolum, carmellosum natricum conexum, acidum citricum, natrii hydrogenocarbonas, magnesii stearas, aromatica (Orange) cum saccharum 1 mg, aspartamum 2 mg, pro compresso corresp. natrium 2.18 mg. | | Packungsbestandteile | | Comprimés orodispersibles | | | | | Principe actif | Concentr. |
|---|
| Zolmitriptan | 2.5 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Zolmitriptan | 2.5 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Acide Citrique | | | Aromatica (Orange) cum Saccharum | 1 mg | | Aspartame | 2 mg | | Carmellosum Natricum Conexum | | | Lactose Monohydrate | 17 mg | | Magnesii Stearas | | | Mannitol | | | Maydis Amylum | | | Sodium Hydrogenocarbonate | | | Pro Compresso | | | Silica Colloidalis Anhydrica | |
| |
| |
|
